Sjgren's syndrome with chronic inflammatory demyelinating polyneuropathy

Neurology India

Volumn 59, Issue 3, 2011, Pages 476-478

  Lin, Wen Sou ^a   Hsu, Yaw Don ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISOLONE; ANTIINFLAMMATORY AGENT; PREDNISONE;

AGED; CASE REPORT; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; DISEASE ASSOCIATION; ELECTRODIAGNOSIS; FEMALE; HUMAN; LETTER; MOTOR UNIT POTENTIAL; NERVE POTENTIAL; SENSORY NERVE ACTION POTENTIAL; SJOEGREN SYNDROME; DRY EYE; MUSCLE WEAKNESS; NERVE CONDUCTION; PHYSIOLOGY; POLYRADICULONEUROPATHY; XEROSTOMIA;

AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; DRY EYE SYNDROMES; ELECTRODIAGNOSIS; FEMALE; HUMANS; MUSCLE WEAKNESS; NEURAL CONDUCTION; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; PREDNISONE; SJOGREN'S SYNDROME; XEROSTOMIA;

EID: 80052193572     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.82754     Document Type: Letter

References (8)

1. Lafitte C. Neurologic manifestations of primary Gougerot-Sjogren syndrome. Rev Neurol (Paris) 1998;154:658-73. (Pubitemid 28513298)
2. Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, et al. Neurologic manifestations in primary Sjogren syndrome: A study of 82 patients. Medicine (Baltimore) 2004;83:280-91. (Pubitemid 39258414)
3. Hughes R, Bensa S, Willison H, Van den Bergh P, Comi G, Illa I, et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001;50:195-201. (Pubitemid 32738144)
4. Vitali C, Bombardieri S, Moutsopoulos HM, Coll J, Gerli R, Hatron PY, et al. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: Results of a prospective multicentre study. Ann Rheum Dis 1996;55:116-21.
5. Vallat JM, Sommer C, Magy L. Chronic inflammatory demyelinating polyradiculoneuropathy: Diagnostic and therapeutic challenges for a treatable condition. Lancet Neurol 2010;9:402-12.
6. San-Juan OD, Castro-Macias JL. Chronic inflammatory demyelinating polyradiculoneuropathy. 10 years' experience in a Mexican centre. Rev Neurol 2008;46:656-9. (Pubitemid 351840355)
7. Magy L, Vallat JM. Evidence-based treatment of chronic immunemediated neuropathies. Expert Opin Pharmacother 2009;10:1741-54.
8. Hughes RA, Gabriel CM, Gregson NA, Smith KJ. Treatment of inflammatory neuropathy. Mult Scler 1997;3:88-92. (Pubitemid 27390380)